静脉注射联合口服钆喷酸葡胺磁共振胆胰管成像在低场强mr的应用.doc

静脉注射联合口服钆喷酸葡胺磁共振胆胰管成像在低场强MR的应用 李岭，于金芬，鲁德会，韩丛丛 （山东省章丘市中医医院MR室，山东 章丘 250200） 摘要：目的 分析口服稀释静脉用钆喷酸葡胺溶液作为低场强磁共振胃肠道阴性对比剂及联合静脉注射钆喷酸葡胺磁共振胆胰管成像（MRCP）在低场MR中用于显示胆胰管及疾病的能力。方法30例临床可疑有胆胰管病变者 in low field MR LI Ling ,YU Jin Fen , LU De Hui , HAN Congcong (MRI, ZHANGQIU CTM HOSPITAL,SHANDONG,250200) Abstract: Objectives: To analyse the capability of oral diluted intra- venous Gd-DTPA solution as a low-field magnetic resonance contrast agents and the gastrointestinal tract negative combined with intravenous injection of Gd-DTPA magnetic resonance cholangiopancreatography (MRCP) in the low-field MR to display pancreatic duct and disease. Methods: 30 cases with suspected pancreatic duct with varying degrees of biliary obstruction, abdominal pain, varying degrees of skin or sclera jaundice, etc., part of the abdominal mass, underwent MR scan, Gd-DTP A (Gd-DTPA) enhanced checks, part of the same line of ultrasound and CT. Results: 30 cases of subjects are able to show clear bile duct tree and location of lesions, including 18 patients with intrahepatic bile duct mass, 10 patients with intrahepatic bile duct, extrahepatic bile duct and (or) gallbladder stones, and 2 cases pancreatic head mass. Conclusion: Oral administration of Gd-DTPA solution inhibit fluid retention within the stomach and duodenum of high background signals and bile duct tree signal of small blood vessels can improve MRCP image quality, combined with hepatobiliary MR scan to strengthen the application of high liver, bile duct display rate and liver, bile duct lesions display capabilities. It is useful for bile duct lesions for the diagnosis and differential diagnosis. MRCP是磁共振胆胰管造影的英文缩写，是利用重T2加权来显示具有非常长T2驰豫时间组织结构的技术。实质性器官如肝脏、脾脏和胰腺的T2时间短，T2序列上表现为低信号。脂肪组织具有中等长度T2的驰豫时间,可通过各种脂肪抑制技术对脂肪信号进行抑制。快速流动液体如门静脉或肝静脉内的血液,由于流动信号在影像上表现为信号缺失,只有流速慢或停滞的液体表现为高信号【1】。而胆管系统内的胆汁属于停滞的液体,因而MRCP可显示胆管系统的形态结构，但由于行MRCP检查时，来自胆胰管树背景上的小血管的重叠信号及胃肠道内液体的同时显影等，导致胆胰管结构显示不清，影响对胆胰管树的观察【2-3】 因此，笔者旨在探讨静脉注射联合口服钆喷酸葡胺抑制胃及十二指肠内潴留液的高信号以及胆胰管树背景的小血管信号，改善MRCP图像的质量的能力，对胆